# US 2024/0189147 A1 · Glaucoma treatment systems and procedures

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0189147 A1
- Document ID: US20240189147A1
- Status: Published application
- Kind: A1
- Application number: 18/568,157
- Filed: 2022-06-30
- Published: 2024-06-13
- Earliest claimed: 2021-06-30
- Assignees: AqueSys, Inc.
- Applicants: AqueSys, Inc.
- Inventors: Laszlo Romoda
- Web page: https://patentgrep.com/patent/US20240189147A1

## CPC

- A61F 9/00781: {Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment (drainage implants in general A61M27/002)}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

Glaucoma treatment can be performed using an intraocular shunt inserter to deliver an intraocular shunt. The shunt can have at least one flow path having an inner diameter of about 50 μm and about 70 μm and between about 170 μm to about 260 μm. The inserter can carry the intraocular shunt within a 27 Gauge needle having a lumen with an inner diameter of between about 220 to about 280 μm. Embodiments of these systems and related procedures can safely and significantly lower glaucoma patient's intraocular pressure and reduce the number of antiglaucoma medications.

## Claims

### Claim 1

A system for treating glaucoma, comprising:
an intraocular shunt made of a cross-linked gelatin, the intraocular shunt having a shunt outer diameter of between about 170 μm to about 260 μm, and the intraocular shunt defining at least one interior flow path having a shunt inner diameter of between about 50 μm and about 70 μm; and
a needle having a lumen to carry the intraocular shunt, the lumen having a lumen inner diameter of between about 220 to about 280 μm.

### Claim 2 (depends on 1)

The system of claim 1, wherein an annular gap between an outer surface of the shunt and an inner surface of the lumen is between about 0 μm to about 20 μm.

### Claim 3 (depends on 1)

The system of claim 1, wherein the shunt outer diameter is expandable.

### Claim 4 (depends on 3)

The system of claim 3, wherein the shunt outer diameter expands to a maximum shunt outer diameter of about 260 μm.

### Claim 5 (depends on 1)

The system of claim 1, wherein the shunt inner diameter is about 63 μm.

### Claim 6 (depends on 1)

The system of claim 1, wherein the intraocular shunt has a shunt wall thickness of between about 88 μm to about 99 μm.

### Claim 7 (depends on 1)

The system of claim 1, wherein the intraocular shunt has a shunt length of about 6 millimeters.

### Claim 8 (depends on 1)

The system of claim 1, wherein the lumen inner diameter is about 260 μm.

### Claim 9 (depends on 1)

The system of claim 1, wherein the needle has a needle outer diameter of between about 400 μm to about 420 μm.

### Claim 10 (depends on 1)

The system of claim 1, wherein the needle has a needle wall thickness of between about 70 μm to about 80 μm.

### Claim 11 (depends on 1)

The system of claim 1, further comprising a movable plunger disposed within the lumen, wherein the plunger is configured to advance the shunt through the lumen.

### Claim 12 (depends on 11)

The system of claim 11, further comprising a deployment mechanism configured to selectively move the plunger to advance the shunt.

### Claim 13

A method to treat glaucoma, the method comprising:
advancing a needle through the sclera of the patient to create an opening, wherein the needle has a needle diameter of between about 400 μm to about 420 μm;
advancing an intraocular shunt through a lumen of the needle and into the opening, wherein the intraocular shunt has a shunt outer diameter of between about 240 to 260 μm and the lumen has a lumen inner diameter of between about 220 μm to about 280 μm for reducing any gap between the shunt and the opening to minimize peritubular flow therebetween, and
permitting flow through the intraocular shunt, wherein the shunt has a shunt inner diameter of between about 50 μm to about 70 μm.

### Claim 14 (depends on 13)

The method of claim 13, further comprising permitting expansion of the intraocular shunt.

### Claim 15 (depends on 14)

The method of claim 14, wherein the shunt outer diameter is limited to approximately the lumen inner diameter during expansion.

### Claim 16 (depends on 13)

The method of claim 13, further comprising expanding the shunt outer diameter to approximately an inner diameter of the opening when the shunt is outside of the lumen of the needle.

### Claim 17 (depends on 13)

The method of claim 13, further comprising cutting the sclera via a tip of the needle to form the opening.

### Claim 18

A system for treating glaucoma, comprising:
an intraocular shunt made of a cross-linked gelatin, the intraocular shunt having a shunt outer diameter of between about 170 μm to about 260 μm, and the intraocular shunt defining at least one interior flow path having a shunt inner diameter of about 63 μm; and
a needle having a lumen to carry the intraocular shunt, the needle having a needle outer diameter of between about 400 μm to about 420 μm and the lumen having a lumen inner diameter of about 260 μm.

### Claim 19 (depends on 18)

The system of claim 18, wherein the intraocular shunt has a shunt wall thickness of between about 88 μm to about 99 μm.

### Claim 20 (depends on 18)

The system of claim 18, wherein the needle has a needle wall thickness of between about 70 μm to about 80 μm.
